Multiplex analyte assays to characterize different dementias: Brain inflammatory cytokines in poststroke and other dementias

Neurobiology of Aging

Volumn 38, Issue , 2016, Pages 56-67

  Chen, Aiqing ^a,b   Oakley, Arthur E ^a,b   Monteiro, Maria ^a,b   Tuomela, Katri ^a,b   Allan, Louise M ^a,b   Mukaetova Ladinska, Elizabeta B ^a,b   O'Brien, John T ^a,b   Kalaria, Raj N ^a,b  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Aging; Cognitive impairment; Immunosenescence; Inflammation; Poststroke dementia; Stroke; Vascular dementia; White matter

Indexed keywords

C REACTIVE PROTEIN; CHEMOKINE; CYTOKINE; GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; INTERLEUKIN 16; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 7; INTERLEUKIN 8; SERUM AMYLOID A; TUMOR NECROSIS FACTOR; AUTACOID; BIOLOGICAL MARKER;

AGED; ALZHEIMER DISEASE; ARTICLE; BRAIN ATROPHY; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; CYTOKINE PRODUCTION; DEMENTIA; FEMALE; FRONTAL LOBE; GRAY MATTER; HUMAN; HUMAN TISSUE; IMMUNOSENESCENCE; MAJOR CLINICAL STUDY; MALE; MIXED DEMENTIA; MULTIINFARCT DEMENTIA; POSTSTROKE DEMENTIA; PRIORITY JOURNAL; TEMPORAL LOBE; WHITE MATTER; AGING; BRAIN; CLASSIFICATION; COGNITION; IMMUNOLOGY; METABOLISM; VERY ELDERLY;

AGED; AGED, 80 AND OVER; AGING; BIOMARKERS; BRAIN; COGNITION; CYTOKINES; DEMENTIA; FEMALE; HUMANS; INFLAMMATION MEDIATORS; MALE;

EID: 84962249547     PISSN: 01974580     EISSN: 15581497     Source Type: Journal    
DOI: 10.1016/j.neurobiolaging.2015.10.021     Document Type: Article

References (57)

1. Allan L.M., Rowan E.N., Firbank M.J., Thomas A.J., Parry S.W., Polvikoski T.M., O'Brien J.T., Kalaria R.N. Long term incidence of dementia, predictors of mortality and pathological diagnosis in older stroke survivors. Brain 2011, 134(Pt 12):3716-3727.
2. Alvarez X.A., Franco A., Fernandez-Novoa L., Cacabelos R. Blood levels of histamine, IL-1 beta, and TNF-alpha in patients with mild to moderate Alzheimer disease. Mol. Chem. Neuropathol. 1996, 29:237-252.
3. Baune B.T., Ponath G., Golledge J., Varga G., Arolt V., Rothermundt M., Berger K. Association between IL-8 cytokine and cognitive performance in an elderly general population-the MEMO-Study. Neurobiol. Aging 2008, 29:937-944.
4. Beridze M., Sanikidze T., Shakarishvili R., Intskirveli N., Bornstein N.M. Selected acute phase CSF factors in ischemic stroke: findings and prognostic value. BMC Neurol. 2011, 11:41.
5. Boraschi D., Italiani P. Immunosenescence and vaccine failure in the elderly: strategies for improving response. Immunol. Lett. 2014, 162(1 Pt B):346-353.
6. Brosseron F., Krauthausen M., Kummer M., Heneka M.T. Body fluid cytokine levels in mild cognitive impairment and Alzheimer's disease: a comparative overview. Mol. Neurobiol. 2014, 50:534-544.
7. Bruunsgaard H., Pedersen A.N., Schroll M., Skinhoj P., Pedersen B.K. Impaired production of proinflammatory cytokines in response to lipopolysaccharide (LPS) stimulation in elderly humans. Clin. Exp. Immunol. 1999, 118:235-241.
8. De Luigi A., Pizzimenti S., Quadri P., Lucca U., Tettamanti M., Fragiacomo C., De Simoni M.G. Peripheral inflammatory response in Alzheimer's disease and multiinfarct dementia. Neurobiol. Dis. 2002, 11:308-314.
9. Deramecourt V., Slade J.Y., Oakley A.E., Perry R.H., Ince P.G., Maurage C.A., Kalaria R.N. Staging and natural history of cerebrovascular pathology in dementia. Neurology 2012, 78:1043-1050.
10. Engelborghs S., De Brabander M., De Cree J., D'Hooge R., Geerts H., Verhaegen H., De Deyn P.P. Unchanged levels of interleukins, neopterin, interferon-gamma and tumor necrosis factor-alpha in cerebrospinal fluid of patients with dementia of the Alzheimer type. Neurochem. Int. 1999, 34:523-530.
11. Falci C., Gianesin K., Sergi G., Giunco S., De Ronch I., Valpione S., Solda C., Fiduccia P., Lonardi S., Zanchetta M., Keppel S., Brunello A., Zafferri V., Manzato E., De Rossi A., Zagonel V. Immune senescence and cancer in elderly patients: results from an exploratory study. Exp. Gerontol. 2013, 48:1436-1442.
12. Felgenhauer K. Protein size and cerebrospinal fluid composition. Klinische Wochenschrift 1974, 52:1158-1164.
13. Frei K., Malipiero U.V., Leist T.P., Zinkernagel R.M., Schwab M.E., Fontana A. On the cellular source and function of interleukin 6 produced in the central nervous system in viral diseases. Eur. J. Immunol. 1989, 19:689-694.
14. Fulop T., Kotb R., Fortin C.F., Pawelec G., de Angelis F., Larbi A. Potential role of immunosenescence in cancer development. Ann. N. Y. Acad. Sci. 2010, 1197:158-165.
15. Gertz K., Kronenberg G., Kalin R.E., Baldinger T., Werner C., Balkaya M., Eom G.D., Hellmann-Regen J., Krober J., Miller K.R., Lindauer U., Laufs U., Dirnagl U., Heppner F.L., Endres M. Essential role of interleukin-6 in post-stroke angiogenesis. Brain 2012, 135(Pt 6):1964-1980.
16. Gimeno D., Marmot M.G., Singh-Manoux A. Inflammatory markers and cognitive function in middle-aged adults: the Whitehall II study. Psychoneuroendocrinology 2008, 33(10):1322-1334.
17. Grubeck-Loebenstein B., Della Bella S., Iorio A.M., Michel J.P., Pawelec G., Solana R. Immunosenescence and vaccine failure in the elderly. Aging Clin. Exp. Res. 2009, 21:201-209.
18. Herrmann O., Tarabin V., Suzuki S., Attigah N., Coserea I., Schneider A., Vogel J., Prinz S., Schwab S., Monyer H., Brombacher F., Schwaninger M. Regulation of body temperature and neuroprotection by endogenous interleukin-6 in cerebral ischemia. J. Cereb. Blood Flow Metab. 2003, 23:406-415.
19. Higgins J.J., Tashtoush S. An aligned rank transform test for interaction. Nonlinear World 1994, 1:201-211.
20. Hoozemans J.J., Veerhuis R., Rozemuller J.M., Eikelenboom P. Soothing the inflamed brain: effect of non-steroidal anti-inflammatory drugs on Alzheimer's disease pathology. CNS Neurol. Disord. Drug Targets 2011, 10:57-67.
21. Hu W.T., Holtzman D.M., Fagan A.M., Shaw L.M., Perrin R., Arnold S.E., Grossman M., Xiong C., Craig-Schapiro R., Clark C.M., Pickering E., Kuhn M., Chen Y., Van Deerlin V.M., McCluskey L., Elman L., Karlawish J., Chen-Plotkin A., Hurtig H.I., Siderowf A., Swenson F., Lee V.M., Morris J.C., Trojanowski J.Q., Soares H. Plasma multianalyte profiling in mild cognitive impairment and Alzheimer disease. Neurology 2012, 79:897-905. Alzheimer's Disease Neuroimaging Initiative.
22. Huberman M., Shalit F., Roth-Deri I., Gutman B., Brodie C., Kott E., Sredni B. Correlation of cytokine secretion by mononuclear cells of Alzheimer patients and their disease stage. J. Neuroimmunol. 1994, 52:147-152.
23. Huberman M., Sredni B., Stern L., Kott E., Shalit F. IL-2 and IL-6 secretion in dementia: correlation with type and severity of disease. J. Neurol. Sci. 1995, 130:161-164.
24. Ihara M., Polvikoski T.M., Hall R., Slade J.Y., Perry R.H., Oakley A.E., Englund E., O'Brien J.T., Ince P.G., Kalaria R.N. Quantification of myelin loss in frontal lobe white matter in vascular dementia, Alzheimer's disease, and dementia with Lewy bodies. Acta Neuropathol. 2010, 119:579-589.
25. Jabbari Azad F., Talaei A., Rafatpanah H., Yousefzadeh H., Jafari R., Talaei A., Farid Hosseini R. Association between cytokine production and disease severity in Alzheimer's disease. Iran J. Allergy Asthma Immunol. 2014, 13:433-439.
26. Jang S., Kelley K.W., Johnson R.W. Luteolin reduces IL-6 production in microglia by inhibiting JNK phosphorylation and activation of AP-1. Proc. Natl. Acad. Sci. U. S. A. 2008, 105:7534-7539.
27. Kalaria R.N., Kenny R.A., Ballard C.G., Perry R., Ince P., Polvikoski T. Towards defining the neuropathological substrates of vascular dementia. J. Neurol. Sci. 2004, 226:75-80.
28. Kern S., Skoog I., Borjesson-Hanson A., Blennow K., Zetterberg H., Ostling S., Kern J., Gudmundsson P., Marlow T., Rosengren L., Waern M. Higher CSF interleukin-6 and CSF interleukin-8 in current depression in older women. Results from a population-based sample. Brain Behav. Immun. 2014, 41:55-58.
29. Kim S.M., Song J., Kim S., Han C., Park M.H., Koh Y., Jo S.A., Kim Y.Y. Identification of peripheral inflammatory markers between normal control and Alzheimer's disease. BMC Neurol. 2011, 11:51.
30. Lee K.S., Chung J.H., Choi T.K., Suh S.Y., Oh B.H., Hong C.H. Peripheral cytokines and chemokines in Alzheimer's disease. Dement. Geriatr. Cogn. Disord. 2009, 28:281-287.
31. Leung R., Proitsi P., Simmons A., Lunnon K., Guntert A., Kronenberg D., Pritchard M., Tsolaki M., Mecocci P., Kloszewska I., Vellas B., Soininen H., Wahlund L.O., Lovestone S. Inflammatory proteins in plasma are associated with severity of Alzheimer's disease. PLoS One 2013, 8:e64971.
32. Licastro F., Pedrini S., Caputo L., Annoni G., Davis L.J., Ferri C., Casadei V., Grimaldi L.M. Increased plasma levels of interleukin-1, interleukin-6 and alpha-1-antichymotrypsin in patients with Alzheimer's disease: peripheral inflammation or signals from the brain?. J. Neuroimmunol. 2000, 103:97-102.
33. Loddick S.A., Turnbull A.V., Rothwell N.J. Cerebral interleukin-6 is neuroprotective during permanent focal cerebral ischemia in the rat. J. Cereb. Blood Flow Metab. 1998, 18:176-179.
34. Montine T.J., Phelps C.H., Beach T.G., Bigio E.H., Cairns N.J., Dickson D.W., Duyckaerts C., Frosch M.P., Masliah E., Mirra S.S., Nelson P.T., Schneider J.A., Thal D.R., Trojanowski J.Q., Vinters H.V., Hyman B.T. National Institute on Aging-Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease: a practical approach. Acta Neuropathol. 2012, 123:1-11. National Institute on Aging, Alzheimer's AssociationAlzheimer's Association.
35. Mulugeta E., Molina-Holgado F., Elliott M.S., Hortobagyi T., Perry R., Kalaria R.N., Ballard C.G., Francis P.T. Inflammatory mediators in the frontal lobe of patients with mixed and vascular dementia. Dement. Geriatr. Cogn. Disord. 2008, 25:278-286.
36. Narasimhalu K., Lee J., Leong Y.L., Ma L., De Silva D.A., Wong M.C., Chang H.M., Chen C. Inflammatory markers and their association with post stroke cognitive decline. Int. J. Stroke 2015, 10:513-518.
37. Rafnsson S.B., Deary I.J., Smith F.B., Whiteman M.C., Rumley A., Lowe G.D., Fowkes F.G. Cognitive decline and markers of inflammation and hemostasis: the Edinburgh Artery Study. J. Am. Geriatr. Soc. 2007, 55:700-707.
38. Richartz E., Batra A., Simon P., Wormstall H., Bartels M., Buchkremer G., Schott K. Diminished production of proinflammatory cytokines in patients with Alzheimer's disease. Dement. Geriatr. Cogn. Disord. 2005, 19:184-188.
39. Richartz E., Stransky E., Batra A., Simon P., Lewczuk P., Buchkremer G., Bartels M., Schott K. Decline of immune responsiveness: a pathogenetic factor in Alzheimer's disease?. J. Psychiatr. Res. 2005, 39(5):535-543.
40. Richartz-Salzburger E., Batra A., Stransky E., Laske C., Kohler N., Bartels M., Buchkremer G., Schott K. Altered lymphocyte distribution in Alzheimer's disease. J. Psychiatr. Res. 2007, 41:174-178.
41. Ron-Harel N., Segev Y., Lewitus G.M., Cardon M., Ziv Y., Netanely D., Jacob-Hirsch J., Amariglio N., Rechavi G., Domany E., Schwartz M. Age-dependent spatial memory loss can be partially restored by immune activation. Rejuvenation Res. 2008, 11:903-913.
42. Schmidt R., Schmidt H., Curb J.D., Masaki K., White L.R., Launer L.J. Early inflammation and dementia: a 25-year follow-up of the Honolulu-Asia Aging Study. Ann. Neurol. 2002, 52:168-174.
43. Schram M.T., Euser S.M., de Craen A.J., Witteman J.C., Frolich M., Hofman A., Jolles J., Breteler M.M., Westendorp R.G. Systemic markers of inflammation and cognitive decline in old age. J. Am. Geriatr. Soc. 2007, 55:708-716.
44. Singh V.K., Guthikonda P. Circulating cytokines in Alzheimer's disease. J. Psychiatr. Res. 1997, 31:657-660.
45. Smith C.J., Denes A., Tyrrell P.J., Di Napoli M. Phase II anti-inflammatory and immune-modulating drugs for acute ischaemic stroke. Expert Opin. Investig. Drugs 2015, 24:623-643.
46. Sudduth T.L., Schmitt F.A., Nelson P.T., Wilcock D.M. Neuroinflammatory phenotype in early Alzheimer's disease. Neurobiol. Aging 2013, 34:1051-1059.
47. Sun Y., Lu C.J., Lin C.H., Wen L.L. Interleukin-1beta is increased in the cerebrospinal fluid of patients with small infarcts. Eur. J. Neurol. 2009, 16:858-863.
48. Suzuki S., Tanaka K., Suzuki N. Ambivalent aspects of interleukin-6 in cerebral ischemia: inflammatory versus neurotrophic aspects. J. Cereb. Blood Flow Metab. 2009, 29:464-479.
49. Swardfager W., Lanctot K., Rothenburg L., Wong A., Cappell J., Herrmann N. A meta-analysis of cytokines in Alzheimer's disease. Biol. Psychiatry 2010, 68:930-941.
50. Tan J., Town T., Abdullah L., Wu Y., Placzek A., Small B., Kroeger J., Crawford F., Richards D., Mullan M. CD45 isoform alteration in CD4+ T cells as a potential diagnostic marker of Alzheimer's disease. J. Neuroimmunol. 2002, 132:164-172.
51. Vila N., Castillo J., Davalos A., Chamorro A. Proinflammatory cytokines and early neurological worsening in ischemic stroke. Stroke 2000, 31:2325-2329.
52. Weaver J.D., Huang M.H., Albert M., Harris T., Rowe J.W., Seeman T.E. Interleukin-6 and risk of cognitive decline: MacArthur studies of successful aging. Neurology 2002, 59:371-378.
53. WesthoffD., Witlox J., Koenderman L., Kalisvaart K.J., de Jonghe J.F., van Stijn M.F., Houdijk A.P., Hoogland I.C., Maclullich A.M., van Westerloo D.J., van de Beek D., Eikelenboom P., van Gool W.A. Preoperative cerebrospinal fluid cytokine levels and the risk of postoperative delirium in elderly hip fracture patients. J. Neuroinflammation 2013, 10:122.
54. Whiteley W., Chong W.L., Sengupta A., Sandercock P. Blood markers for the prognosis of ischemic stroke: a systematic review. Stroke 2009, 40:e380-e389.
55. Whiteley W., Wardlaw J., Dennis M., Lowe G., Rumley A., Sattar N., Welsh P., Green A., Andrews M., Sandercock P. The use of blood biomarkers to predict poor outcome after acute transient ischemic attack or ischemic stroke. Stroke 2012, 43:86-91.
56. Wright C.B., Sacco R.L., Rundek T., Delman J., Rabbani L., Elkind M. Interleukin-6 is associated with cognitive function: the Northern Manhattan Study. J. Stroke Cerebrovasc. Dis. 2006, 15:34-38.
57. Yamada K., Kono K., Umegaki H., Yamada K., Iguchi A., Fukatsu T., Nakashima N., Nishiwaki H., Shimada Y., Sugita Y., Yamamoto T., Hasegawa T., Nabeshima T. Decreased interleukin-6 level in the cerebrospinal fluid of patients with Alzheimer-type dementia. Neurosci. Lett. 1995, 186:219-221.